Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)

Market Cap	10.27B -15.1%
Revenue (ttm)	3.91B +4.5%
Net Income	590.51M +10.6%
EPS	1.37 +10.4%
Shares Out	431.05M
PE Ratio	17.39
Forward PE	15.28
Dividend	0.70 (3.00%)
Ex-Dividend Date	Aug 8, 2025

Volume	4,728,634
Open	23.32
Previous Close	23.32
Day's Range	23.17 - 23.84
52-Week Range	23.09 - 30.18
Beta	0.32
Analysts	Strong Buy
Price Target	36.25 (+52.12%)
Earnings Date	Aug 28, 2026

About SHA:600993

Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells Chinese and Western medicines in China and internationally. The company offers functional cosmetics, functional care products and food, Chinese herbal medicines, and medical devices. It also manufactures, processes, and sells medicinal packaging materials, cosmetics, and Chinese medicines; and offers first and second category medical devices, household products, electronic products, daily necessities, hygiene products, and disinfection products, as...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1582
• Employees: 2,544
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600993

Financial Performance

In 2025, SHA:600993's revenue was 3.87 billion, an increase of 3.72% compared to the previous year's 3.73 billion. Earnings were 581.49 million, an increase of 10.11%.

Analyst Summary

According to 2 analysts, the average rating for 600993 stock is "Strong Buy." The 12-month stock price target is ¥36.25, which is an increase of 52.12% from the latest price.

Price Target

¥36.25

(52.12% upside)

Analyst Consensus: Strong Buy